CDTX Competitors & Alternatives
Compare Cidara Therapeutics Inc with similar stocks in the same industry
Biotechnology
CDTX
Main Stock$221.38
Tradestie Score
50
Market Cap
$2.44B
Revenue Growth
-1.0%
Analyst Upside
+0.1%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$214.65
|
$8.30B | 14.5 | 62 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$62.33
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$90.90
|
$6.64B | - | 70 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.23
|
$6.38B | - | 61 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.90
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.99
|
$6.02B | - | 66 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$156.07
|
$5.92B | - | 49 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.16
|
$5.80B | 19.3 | 59 | Compare |
More CDTX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry